LOS ANGELES, CA - December 10, 2025 (NEWMEDIAWIRE) - HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through personalized insights, received FDA 510(k) ...
Abstract: Online collision-free trajectory generation within a shared workspace is fundamental for most multirobot applications. However, many widely-used methods based on model predictive control ...
Abstract: Optimizing look-ahead distance for the pure pursuit has been an important issue as it determines the relation between the smooth path tracking performance ...
In its October meeting, the MPC kept the repo rate steady at 5.5% for a fourth straight time. RBI Governor Sanjay Malhotra had then said that inflation had moderated sharply, giving the committee ...
Hosted on MSN
HeartBeam (NASDAQ: BEAT) Outlines Regulatory Strategy After NSE Decision on ECG Synthesis Software
Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our ...
LOS ANGELES, CA - December 1, 2025 (NEWMEDIAWIRE) - HeartBeam (NASDAQ: BEAT), a medical technology company developing personalized cardiac-care insights, detailed its strategy following receipt of a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback